Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 7Neoplasms 6Colonic Neoplasms 3Urinary Bladder Neoplasms 2Respiratory Aspiration 2Prostatic Neoplasms 2Uterine Neoplasms 1Thyroid Neoplasms 1Rectal Neoplasms 1Quality of Recovery 1Postoperative Complications 1Postoperative Cognitive Complications 1Pituitary Neoplasms 1Neurofibromatoses 1Myofibroma 1Melanoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Inflammation 1Hypoxia 1Hydrocephalus 1Headache 1Female Breast Carcinoma 1Epilepsy 1Endoplasmic Reticulum Stress 1Delirium 1Cough 1Abdominal Neoplasms 1

Interventions

aldesleukin 26Sunitinib 25Interferon-alpha 21Everolimus 18Sorafenib 16Cyclophosphamide 16Filgrastim 13Bevacizumab 13Nivolumab 11Gemcitabine 11Interleukin-2 10Axitinib 10fludarabine phosphate 9Gene Expression Profiling 9temsirolimus 8Peripheral Blood Stem Cell Transplantation 8Doxorubicin 8pembrolizumab 7Radiotherapy 6Radiosurgery 6Polymerase Chain Reaction 6Ipilimumab 6Carboplatin 6sargramostim 5Ifosfamide 5Fluorouracil 5Erlotinib Hydrochloride 5Capecitabine 5Bortezomib 5atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Kidney Neoplasms × Sevoflurane × Clear all
NCT03514550 2019-06-03

Effects of Anesthesia on Immunity in Cancer

Meshalkin Research Institute of Pathology of Circulation

Phase 4 Completed
20 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡